يعرض 1 - 10 نتائج من 215 نتيجة بحث عن '"Kupper, Hartmut"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double‐Blind, Active‐Controlled Proof‐of‐Concept Phase IIa Trial

    المؤلفون: Buttgereit, Frank, Aelion, Jacob, Rojkovich, Bernadette, Zubrzycka‐Sienkiewicz, Anna, Chen, Su, Yang, Yang, Arikan, Dilek, D'Cunha, Ronilda, Pang, Yinuo, Kupper, Hartmut, Radstake, Timothy, Amital, Howard

    المساهمون: AbbVie

    المصدر: Arthritis & Rheumatology ; volume 75, issue 6, page 879-889 ; ISSN 2326-5191 2326-5205

    الإتاحة: https://doi.org/10.1002/art.42415Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    A first‐in‐human study of the novel immunology antibody–drug conjugate, ABBV‐3373, in healthy participants

    المؤلفون: D'Cunha, Ronilda, Kupper, Hartmut, Arikan, Dilek, Zhao, Weihan, Carter, David, Blaes, Jonas, Ruzek, Melanie, Pang, Yinuo

    المساهمون: AbbVie

    المصدر: British Journal of Clinical Pharmacology ; volume 90, issue 1, page 189-199 ; ISSN 0306-5251 1365-2125

    الإتاحة: https://doi.org/10.1111/bcp.15888Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    A first‐in‐human study of the novel immunology antibody–drug conjugate, ABBV‐3373, in healthy participants.

    المؤلفون: D'Cunha, Ronilda1 (AUTHOR), Kupper, Hartmut2 (AUTHOR), Arikan, Dilek1 (AUTHOR), Zhao, Weihan1 (AUTHOR), Carter, David1 (AUTHOR), Blaes, Jonas2 (AUTHOR), Ruzek, Melanie3 (AUTHOR), Pang, Yinuo1 (AUTHOR) yinuo.pang@abbvie.com

    المصدر: British Journal of Clinical Pharmacology. Jan2024, Vol. 90 Issue 1, p189-199. 11p.

    مصطلحات موضوعية: *ANTIBODY-drug conjugates, *GLUCOCORTICOID receptors, *IMMUNOLOGY, *IMMUNE response, *IMMUNOGLOBULINS, *HYDROCORTISONE

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven‐Year Interim Results

    المؤلفون: Brunner, Hermine I., Nanda, Kabita, Toth, Mary, Foeldvari, Ivan, Bohnsack, John, Milojevic, Diana, Rabinovich, C. Egla, Kingsbury, Daniel J., Marzan, Katherine, Chalom, Elizabeth, Horneff, Gerd, Kuester, Rolf‐Michael, Dare, Jason A., Trachana, Maria, Jung, Lawrence K., Olson, Judyann, Minden, Kirsten, Quartier, Pierre, Bereswill, Mareike, Kalabic, Jasmina, Kupper, Hartmut, Lovell, Daniel J., Martini, Alberto, Ruperto, Nicolino

    المساهمون: AbbVie

    المصدر: Arthritis Care & Research ; volume 72, issue 10, page 1420-1430 ; ISSN 2151-464X 2151-4658

    الإتاحة: https://doi.org/10.1002/acr.24044Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis

    المؤلفون: Kavanaugh, Arthur, van Vollenhoven, Ronald F, Fleischmann, Roy, Emery, Paul, Sainsbury, Iain, Florentinus, Stefan, Chen, Su, Guérette, Benoît, Kupper, Hartmut, Smolen, Josef S

    المصدر: Kavanaugh , A , van Vollenhoven , R F , Fleischmann , R , Emery , P , Sainsbury , I , Florentinus , S , Chen , S , Guérette , B , Kupper , H & Smolen , J S 2018 , ' Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis ' , Annals of the Rheumatic Diseases , vol. 77 , no. 2 , pp. 289-292 . https://doi.org/10.1136/annrheumdis-2017-211871Test

    العلاقة: https://research.vumc.nl/en/publications/50389511-a008-4e49-baf5-22def434540cTest

    الإتاحة: https://doi.org/10.1136/annrheumdis-2017-211871Test
    https://research.vumc.nl/en/publications/50389511-a008-4e49-baf5-22def434540cTest

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial

    المؤلفون: Kaeley, Gurjit S., MacCarter, Daryl K., Goyal, Janak R., Liu, Shufang, Chen, Kun, Griffith, Jennifer, Kupper, Hartmut, Garg, Vishvas, Kalabic, Jasmina

    المساهمون: AbbVie

    المصدر: Rheumatology and Therapy ; volume 5, issue 1, page 123-134 ; ISSN 2198-6576 2198-6584

    مصطلحات موضوعية: Immunology and Allergy, Rheumatology

    الإتاحة: https://doi.org/10.1007/s40744-018-0105-7Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis

    المؤلفون: Keystone, Edward C, Breedveld, Ferdinand C, Kupper, Hartmut, Li, Yihan, Florentinus, Stefan, Sainsbury, Iain

    المساهمون: AbbVie

    المصدر: RMD Open ; volume 4, issue 1, page e000637 ; ISSN 2056-5933

    الإتاحة: https://doi.org/10.1136/rmdopen-2017-000637Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab

    المؤلفون: Burmester, Gerd R, Kaeley, Gurjit S, Kavanaugh, Arthur F, Gabay, Cem, MacCarter, Daryl K, Nash, Peter, Takeuchi, Tsutomu, Goss, Sandra L, Rodila, Ramona, Chen, Kun, Kupper, Hartmut, Kalabic, Jasmina

    المصدر: ISSN: 2056-5933 ; RMD Open, vol. 3, no. 2 (2017) e000465.

    مصطلحات موضوعية: info:eu-repo/classification/ddc/616

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28955494; https://archive-ouverte.unige.ch/unige:110660Test; unige:110660

    الإتاحة: https://doi.org/10.1136/rmdopen-2017-000465Test
    https://archive-ouverte.unige.ch/unige:110660Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    RMD Open: Rheumatic & Musculoskeletal Diseases / Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone

    المؤلفون: Keystone, Edward C., Smolen, Josef S., Breedveld, Ferdinand C., Van der Heijde, Désirée, Van Vollenhoven, Ronald F., Emery, Paul, Sainsbury, Iain, Florentinus, Stefan, Kupper, Hartmut, Chen, Kun, Kavanaugh, Arthur

    جغرافية الموضوع: UMW:14572

    وصف الملف: text/html

    العلاقة: vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-48639/128Test; urn:nbn:at:at-ubmuw:3-48639; https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:3-48639Test; local:99146156791803331; system:AC16252310

    الإتاحة: https://doi.org/10.1136/rmdopen-2017-000445Test
    https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:3-48639Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone

    المؤلفون: Keystone, Edward C, Breedveld, Ferdinand C, Heijde, Désirée van der, van Vollenhoven, Ronald F, Emery, Paul, Smolen, Josef S, Sainsbury, Iain, Florentinus, Stefan, Kupper, Hartmut, Chen, Kun, Kavanaugh, Arthur

    المساهمون: AbbVie Inc.

    المصدر: RMD Open ; volume 3, issue 2, page e000445 ; ISSN 2056-5933

    مصطلحات موضوعية: Immunology, Immunology and Allergy, Rheumatology

    الإتاحة: https://doi.org/10.1136/rmdopen-2017-000445Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث